ADHD 300: Beyond the Basics
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program will be awarded 1.0 NAPNAP contact hours, of which 0.5 is pharmacology content/1.0 Psychopharmacology content/0 Controlled Substance content.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: email@example.com
This presentation was supported by an education grant from Supernus.
Copyright 2020 © by National Association of Pediatric Nurse Practitioners (NAPNAP).
Keywords: ADHD, psychopharmacology, anxiety, depression
Pediatric-focused advanced practice registered nurses
- Integrate knowledge of the psychopharmacology of medications used for ADHD, anxiety and depression into their primary care patient management plans
- Evaluate the effectiveness of these agents in primary care patients
- Identify warning signs of significant medication- related side effects
- Incorporate patient and family teaching strategies to improve psychopharmacologic treatment
Dawn Garzon Maaks, PhD, CPNP-PC, PMHS, FAANP, University of Portland School of Nursing
- 1.00 Contact hours